Design and synthesis of novel pyridazine N-aryl acetamides: In-vitro evaluation of α-glucosidase inhibition, docking, and kinetic studies

被引：19
|
作者：
Moghimi, Setareh [1 ]
Toolabi, Mahsa [2 ]
Salarinejad, Somayeh [3 ]
Firoozpour, Loghman [1 ]
Ebrahimi, Seyed Esmaeil Sadat [3 ]
Safari, Fatemeh [4 ]
Mojtabavi, Somayeh [5 ]
Faramarzi, Mohammad Ali [5 ]
Foroumadi, Alireza [1 ,3 ]
机构：
[1] Univ Tehran Med Sci, Inst Pharmaceut Sci TIPS, Drug Design & Dev Res Ctr, Tehran, Iran
[2] Ahvaz Jundishapur Univ Med Sci, Sch Pharm, Dept Med Chem, Ahvaz, Iran
[3] Univ Tehran Med Sci, Fac Pharm, Dept Med Chem, Tehran, Iran
[4] Univ Guilan, Fac Sci, Dept Biol, Rasht, Iran
[5] Univ Tehran Med Sci, Fac Pharm, Dept Pharmaceut Biotechnol, Tehran, Iran
来源：
BIOORGANIC CHEMISTRY | 2020年 / 102卷
基金：
美国国家科学基金会;
关键词：
Pyridazine; Glucosidase inhibitor; Lawesson's reagent; Antidiabetic drug; BIOLOGICAL EVALUATION; MOLECULAR DOCKING; POTENT; DRUG; BIOISOSTERISM; DERIVATIVES;
D O I：
10.1016/j.bioorg.2020.104071
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
We herein applied the four step-synthetic route to prepare the pyridazine core attached to the various N-aryl acetamides. By this approach, a new series of pyridazine-based compounds were synthesized, characterized and evaluated for their activities against alpha-glucosidase enzyme. In-vitro alpha-glucosidase assay established that twelve compounds are more potent than acarbose. Compound 7a inhibited alpha-glucosidase with the IC50 value of 70.1 mu M. The most potent compounds showed no cytotoxicity against HDF cell line. Molecular docking and kinetic studies were performed to determine the modes of interaction and inhibition, respectively.
引用
收藏
页数：9
相关论文
共 50 条
  • [1] Synthesis, in-vitro evaluation, molecular docking, and kinetic studies of pyridazine-triazole hybrid system as novel α-glucosidase inhibitors
    Moghimi, Setareh
    Salarinejad, Somayeh
    Toolabi, Mahsa
    Firoozpour, Loghman
    Ebrahimi, Seyed Esmaeil Sadat
    Safari, Fatemeh
    Madani-Qamsari, Fatemeh
    Mojtabavi, Somayeh
    Faramarzi, Mohammad Ali
    Karima, Saeed
    Pakrad, Roya
    Foroumadi, Alireza
    BIOORGANIC CHEMISTRY, 2021, 109
  • [2] Synthesis of novel flavone hydrazones: In-vitro evaluation of α-glucosidase inhibition, QSAR analysis and docking studies
    Imran, Syahrul
    Taha, Muhammad
    Ismail, Nor Hadiani
    Kashif, Syed Muhammad
    Rahim, Fazal
    Jamil, Waqas
    Hariono, Maywan
    Yusuf, Muhammad
    Wahab, Habibah
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 105 : 156 - 170
  • [3] Synthesis of amantadine clubbed N-aryl amino thiazoles as potent urease, α-amylase & α-glucosidase inhibitors, kinetic and molecular docking studies
    Zahra, Fatima Tuz
    Saeed, Aamer
    Ahmed, Atteeque
    Ismail, Hammad
    Ijaz, Muhammad Umar
    Albericio, Fernando
    RSC ADVANCES, 2023, 13 (36) : 24988 - 25001
  • [4] Novel C-2 Symmetric Molecules as -Glucosidase and -Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics
    Shahzad, Danish
    Saeed, Aamer
    Larik, Fayaz Ali
    Channar, Pervaiz Ali
    Abbas, Qamar
    Alajmi, Mohamed F.
    Arshad, M. Ifzan
    Erben, Mauricio F.
    Hassan, Mubashir
    Raza, Hussain
    Seo, Sung-Yum
    El-Seedi, Hesham R.
    MOLECULES, 2019, 24 (08)
  • [5] Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies
    Asgari, Mohammad Sadegh
    Mohammadi-Khanaposhtani, Maryam
    Kiani, Mitra
    Ranjbar, Parviz Rashidi
    Zabihi, Ebrahim
    Pourbagher, Roghayeh
    Rahimi, Rahmatollah
    Faramarzi, Mohammad Ali
    Biglar, Mahmood
    Larijani, Bagher
    Mahdavi, Mohammad
    Hamedifar, Haleh
    Hajimiri, Mir Hamed
    BIOORGANIC CHEMISTRY, 2019, 92
  • [6] Design, synthesis, in-vitro and in-silico studies of novel N- heterocycle based hydrazones as α-glucosidase inhibitors
    Farooqi, Rehmatullah
    Ullah, Saeed
    Khan, Ajmal
    Gurav, Shailesh S.
    Mali, Suraj N.
    Aftab, Hina
    Al-Sadoon, Mohammad Khalid
    Hsu, Ming-Hua
    Taslimi, Parham
    Al-Harrasi, Ahmed
    Shafiq, Zahid
    Schenone, Silvia
    BIOORGANIC CHEMISTRY, 2025, 156
  • [7] Design, synthesis, and inhibition of α-glucosidase by novel L-phenylalanine-derived hydrazones: Kinetic, molecular docking, and dynamics studies
    Kalay, Erbay
    Adem, Sevki
    Demir, Yeliz
    Aslan, Osman Nuri
    Sahin, Engin
    Eyupoglu, Volkan
    Rawat, Ravi
    Comakli, Veysel
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2025, 768
  • [8] Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study
    Saeedi, Mina
    Mohammadi-Khanaposhtani, Maryam
    Pourrabia, Parvaneh
    Razzaghi, Nima
    Ghadimi, Reza
    Imanparast, Somaye
    Faramarzi, Mohammad Ali
    Bandarian, Fatemeh
    Esfahani, Ensieh Nasli
    Safavi, Maliheh
    Rastegar, Hossein
    Larijani, Bagher
    Mandavi, Mohammad
    Akbarzadeh, Tahmineh
    BIOORGANIC CHEMISTRY, 2019, 83 : 161 - 169
  • [9] Novel tetracycline hybrids: synthesis, characterization, docking studies and in-vitro evaluation of antibacterial activity
    Shah, Mansi
    Suhagia, Bhanubhai
    Goswami, Sunita
    Sagar, Sneha
    Patwari, Arpit
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2025, 11 (01)
  • [10] Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies
    Peytam, Fariba
    Adib, Mehdi
    Shourgeshty, Reihaneh
    Mohammadi-Khanaposhtani, Maryam
    Jahani, Mehdi
    Imanparast, Somaye
    Faramarzi, Mohammad Ali
    Mahdavi, Mohammad
    Moghadamnia, Ali Akbar
    Rastegar, Hossein
    Larijani, Bagher
    MOLECULAR DIVERSITY, 2020, 24 (01) : 69 - 80
12345